Livzon Pharmaceutical Group Inc. — Proxy Solicitation & Information Statement 2015

Nov 2, 2015

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [76 x 33] intentionally omitted <==

麗珠醫藥集團股份有限公司 LIVZON PHARMACEUTICAL GROUP INC.[*]

(a joint stock company incorporated in the People’s Republic of China with limited liability)

(Stock code: 1513)

NOTICE OF THE 2015 THIRD EXTRAORDINARY GENERAL MEETING

NOTICE IS HEREBY GIVEN that the 2015 Third Extraordinary General Meeting of 麗珠 醫藥集團股份有限公司 Livzon Pharmaceutical Group Inc.* (the “ Company ”) (the “ EGM ”) will be held at the Conference Room on the 2nd Floor of Livzon Building, 132 Guihua North Road, Gongbei, Zhuhai, Guangdong Province, China at 2:00 p.m. on Monday, 21 December 2015, agenda of which is as below:

I. Basic Information of the Meeting

1. Convenor: The board of directors of the Company (the “ Board ”)

2. Convention time: 2:00 p.m. on Monday, 21 December 2015

3. Venue: Conference Room on the 2nd Floor of Livzon Building, 132 Guihua North Road, Gongbei, Zhuhai, Guangdong Province, China

4. Way of conducting the meeting: Poll at the meeting (Refers only to the meeting attending method for H Shareholders of the Company)

1

II. Matters to be considered at the Meeting--Special Resolutions

1. To consider and approve the Company’s fulfillment of the conditions of the nonpublic issuance of A shares.

2. To consider and approve one by one the proposal of non-public issuance of A shares of the Company.

   • 2.1 Types and par value of shares to be issued

   • 2.2 Amount to be issued

   • 2.3 Method and time of issuance

   • 2.4 Targets of issuance and subscription method

   • 2.5 Pricing method and issuing price

   • 2.6 Restricted period

   • 2.7 Place of listing

   • 2.8 Use of proceeds and amounts

   • 2.9 Ownership of undistributed profits of the Company accrued before this nonpublic issuance

   • 2.10 Valid period of resolution

3. To consider and approve the contingency plan of non-public issuance of A shares of the Company.

4. To consider and approve the feasibility analysis report on the usage of the funds raised by the non-public issuance of A shares of the Company.

5. To consider and approve the connected transactions constituted by the non-public issuance of A shares of the Company.

2

1. To consider and approve the authorization proposed to be granted to the Board at the shareholders’ meeting to be fully in-charge of the management of the relevant matters on the non-public issuance of A shares.

2. To consider and approve the full-scale amendment of “Administrative Measures on the Usage of Funds raised by Livzon Pharmaceutical Group Inc.”.

Notes:

1. All resolutions at the EGM will be taken by poll (except where the chairman decides to allow a resolution relating to a procedural or administrative matter to be voted on by a show of hands) pursuant to the Rules Governing the Listing of Securities on the Stock Exchange of Hong Kong Limited (the “ Hong Kong Listing Rules ”). The results of the poll will be published on the websites of Hong Kong Exchanges and Clearing Limited (www.hkexnews.hk) and the Company (www.livzon.com.cn) in accordance with the Hong Kong Listing Rules.

2. For the purpose of determining the qualification of the shareholders who are entitled to attend and vote at the EGM, the register of members of the Company will be closed from Thursday, 19 November 2015 to Monday, 21 December 2015, both days inclusive, during which period no transfer of shares will be registered. In order to be qualified as shareholders to attend and vote at the EGM, holders of H shares of the Company (“ H Shareholders ”) who are not registered must lodge all transfers of shares accompanied by the relevant share certificates with the Company’s H Share Registrar, Tricor Investor Services Limited, at Level 22, Hopewell Centre, 183 Queen’s Road East, Hong Kong for registration no later than 4:30 p.m. on Wednesday, 18 November 2015.

3. Any shareholder of the Company entitled to attend and vote at the EGM is entitled to appoint one or more persons as his proxy to attend and vote in his stead. A proxy need not be a shareholder of the Company. If more than one proxy is so appointed, the appointment shall specify the number and class of shares in respect of which each such proxy is so appointed.

4. Any shareholders who intend to attend the EGM shall complete the reply slip for attendance in accordance with the instructions printed thereon and return to the Secretariat of the Board (for A Shareholders) or the H Share Registrar of the Company, Tricor Investor Services Limited, at Level 22, Hopewell Centre, 183 Queen’s Road East, Hong Kong (for H Shareholders) on or before Tuesday, 1 December 2015, either in person, by mail or fax.

5. A shareholder shall attend the EGM by his proxy duly authorised in writing. The instrument appointing a proxy must be signed by the shareholder(s) or his/her/its attorney duly authorised in writing. Where the shareholder is a legal person, the proxy form shall be executed under its common seal or under the hand of its director or a legal representative or an attorney duly authorised. If the proxy form is signed by the attorney of the shareholder, the power of attorney or other documents of authorisation must be notarised. To be valid, the A Shareholders must lodge the proxy form and the notarised power of attorney or other

3

documents of authorization (if any) with the Secretariat of the Board at 132 Guihua North Road, Gongbei, Zhuhai, Guangdong Province, China (postal code: 519020) not less than 24 hours before the holding of the EGM. To be valid, the H Shareholders must lodge the proxy form with the H Share Registrar of the Company, Tricor Investor Services Limited, at Level 22, Hopewell Centre, 183 Queen’s Road East, Hong Kong not less than 24 hours before the holding of the EGM. Completion and return of the proxy form will not preclude shareholders from attending and voting at the EGM or any adjournment thereof in person, and in such event, the proxy form shall be deemed to be revoked.

1. Contact details of the Secretariat of the Board are as follows:

Address: Office of the Secretariat of the Board, Livzon Pharmaceutical Group Inc., 132 Guihua North Road, Gongbei, Zhuhai, Guangdong Province, China Postal code: 519020 Contact persons: Mr. Wang Shuguang, Ms. Yuan Ailing Telephone: (86) 756 8135888 Fax: (86) 756 8891070

1. Shareholders or their proxies shall produce their identity proof when attending the EGM.

2. The EGM is expected to last for one hour. Shareholders who attend the EGM (in person or by proxy) should be responsible for their own travelling, lodging and the related costs.

By order of the Board 麗珠醫藥集團股份有限公司 Livzon Pharmaceutical Group Inc. Yang Liang*

Company Secretary

Zhuhai, China

3 November 2015

As at the date of this announcement, the Executive Directors of the Company are Mr. Tao Desheng (Vice Chairman and President), Mr. Fu Daotian (Vice President) and Mr. Yang Daihong (Vice President); the Non-Executive Directors of the Company are Mr. Zhu Baoguo (Chairman), Mr. Qiu Qingfeng and Mr. Zhong Shan; and the Independent Non-Executive Directors of the Company are Mr. Xu Yanjun, Mr. Guo Guoqing, Mr. Wang Xiaojun, Mr. Zheng Zhihua and Mr. Xie Yun.

• For identification purpose only

4